PCSK9 drives sterol-dependent metastatic organ choice in pancreatic cancer.

Saved in:
Bibliographic Details
Title: PCSK9 drives sterol-dependent metastatic organ choice in pancreatic cancer.
Authors: Rademaker G; Department of Anatomy, University of California San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA., Hernandez GA; Department of Anatomy, University of California San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA., Seo Y; Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Dahal S; Department of Anatomy, University of California San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA., Miller-Phillips L; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.; Department of Hematology/Oncology, LMU Klinikum, University of Munich Comprehensive Cancer Center, Munich, Germany., Li AL; Department of Anatomy, University of California San Francisco, San Francisco, CA, USA., Peng XL; Department of Pharmacology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Luan C; Department of Pharmacology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Qiu L; Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Liegeois MA; Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, USA., Wang B; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.; Division of Gastroenterology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Wen KW; Department of Pathology, University of California San Francisco, San Francisco, CA, USA., Kim GE; Department of Pathology, University of California San Francisco, San Francisco, CA, USA., Collisson EA; Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Kruger SF; Department of Hematology/Oncology, LMU Klinikum, University of Munich Comprehensive Cancer Center, Munich, Germany., Boeck S; Department of Hematology/Oncology, LMU Klinikum, University of Munich Comprehensive Cancer Center, Munich, Germany.; Department of Hematology and Oncology, München Klinik Neuperlach, Munich, Germany.; German Cancer Consortium (DKTK), Munich, Germany., Ormanns S; Institute of General Pathology, Medical University Innsbruck, Innsbruck, Austria.; Innpath Institute for Pathology, Tirol Kliniken, Innsbruck, Austria., Guenther M; Institute of General Pathology, Medical University Innsbruck, Innsbruck, Austria.; Innpath Institute for Pathology, Tirol Kliniken, Innsbruck, Austria., Heinemann V; Department of Hematology/Oncology, LMU Klinikum, University of Munich Comprehensive Cancer Center, Munich, Germany., Haas M; Department of Hematology/Oncology, LMU Klinikum, University of Munich Comprehensive Cancer Center, Munich, Germany.; Department of Hematology and Oncology, München Klinik Neuperlach, Munich, Germany., Looney MR; Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Yeh JJ; Department of Pharmacology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Departments of Surgery and Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Zoncu R; Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, CA, USA., Perera RM; Department of Anatomy, University of California San Francisco, San Francisco, CA, USA. rushika.perera@ucsf.edu.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. rushika.perera@ucsf.edu.; Department of Pathology, University of California San Francisco, San Francisco, CA, USA. rushika.perera@ucsf.edu.
Source: Nature [Nature] 2025 Jul; Vol. 643 (8074), pp. 1381-1390. Date of Electronic Publication: 2025 May 21.
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Research Support, N.I.H., Extramural
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-4687
DOI:10.1038/s41586-025-09017-8